Reviewed,
UniProtKB/Swiss-Prot Q13428 (TCOF_HUMAN)
Last modified
July 7, 2009.
Version 86.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Treacle protein Alternative name(s): Treacher Collins syndrome protein | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1488 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May be involved in nucleolar-cytoplasmic transport. May play a fundamental role in early embryonic development, particularly in development of the craniofacial complex By similarity. |
| Subcellular location | |
| Post-translational modification | Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 |
| Involvement in disease | Defects in TCOF1 are the cause of Treacher Collins syndrome (TCS) [MIM:154500]. TCS is an autosomal dominant disorder of craniofacial development that occurs with an incidence of 1/50,000 live births. The clinical features of TCS are bilaterally symmetrical and include: (1) abnormalities of the external ears, atresia of the external ear canals, and malformation of the middle ear ossicles, which may result in conductive hearing loss; (2) lateral downward sloping of palpebral fissures, frequently with colobomas of the lower eyelids; (3) hypoplasia of the mandible and zygomatic complex; (4) cleft palate. Ref.16 |
| Sequence similarities | Contains 1 LisH domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transport |
| Cellular component | Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Disease mutation |
| PTM | Phosphoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | skeletal system development Ref.3 Traceable author statement. Source: ProtInc transportInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | nucleolus Ref.3 Inferred from direct assay. Source: MGI |
| Molecular function | protein binding Inferred from physical interaction. Source: IntAct transporter activity Ref.3Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ARRB1 | P49407 | 2 | EBI-396105,EBI-743313 | |
| ARRB2 | P32121 | 2 | EBI-396105,EBI-714559 |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q13428-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Major. | ||||||
| Isoform 2 (identifier: Q13428-2) The sequence of this isoform differs from the canonical sequence as follows: 214-290: Missing. 1172-1172: L → LV | ||||||
| Isoform 3 (identifier: Q13428-3) The sequence of this isoform differs from the canonical sequence as follows: 1172-1172: L → LV | ||||||
| Isoform 4 (identifier: Q13428-4) The sequence of this isoform differs from the canonical sequence as follows: 953-953: Q → QDSNSKPARSKTLAPAPPERNTEGSSESSEEELPLTQ | ||||||
| Note: Minor. | ||||||
| Isoform 5 (identifier: Q13428-5) The sequence of this isoform differs from the canonical sequence as follows: 954-958: VIKPP → DQESS 959-1488: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1488 | 1488 | Treacle protein | PRO_0000072459 | |||||
Regions | |||||||||
| Domain | 6 – 38 | 33 | LisH | ||||||
| Compositional bias | 89 – 97 | 9 | Poly-Glu | ||||||
| Compositional bias | 204 – 207 | 4 | Poly-Ser | ||||||
| Compositional bias | 693 – 696 | 4 | Poly-Ser | ||||||
| Compositional bias | 996 – 1001 | 6 | Poly-Ser | ||||||
| Compositional bias | 1362 – 1366 | 5 | Poly-Lys | ||||||
| Compositional bias | 1452 – 1463 | 12 | Poly-Lys | ||||||
| Compositional bias | 1475 – 1482 | 8 | Poly-Lys | ||||||
Amino acid modifications | |||||||||
| Modified residue | 83 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 84 | 1 | Phosphothreonine Ref.7 Ref.15 | ||||||
| Modified residue | 85 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 87 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 88 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 138 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 144 | 1 | Phosphothreonine Ref.10 | ||||||
| Modified residue | 153 | 1 | Phosphoserine Ref.10 Ref.12 Ref.15 | ||||||
| Modified residue | 156 | 1 | Phosphoserine Ref.9 Ref.12 Ref.15 | ||||||
| Modified residue | 160 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 164 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 171 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 173 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 233 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 249 | 1 | Phosphothreonine Ref.8 Ref.15 | ||||||
| Modified residue | 304 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 310 | 1 | Phosphothreonine Ref.9 Ref.15 | ||||||
| Modified residue | 316 | 1 | Phosphothreonine Ref.9 Ref.15 | ||||||
| Modified residue | 339 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 342 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 343 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 347 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 349 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 381 | 1 | Phosphoserine Ref.9 Ref.10 Ref.12 Ref.15 | ||||||
| Modified residue | 394 | 1 | Phosphothreonine Ref.10 | ||||||
| Modified residue | 413 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 414 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 417 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 419 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 430 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 446 | 1 | Phosphoserine Ref.7 Ref.9 Ref.10 | ||||||
| Modified residue | 475 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 477 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 478 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 479 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 482 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 484 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 503 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 545 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 547 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 548 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 549 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 581 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 582 | 1 | Phosphoserine Ref.9 Ref.12 | ||||||
| Modified residue | 583 | 1 | Phosphoserine Ref.9 Ref.10 Ref.12 Ref.15 | ||||||
| Modified residue | 608 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 610 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 611 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 614 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 615 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 617 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 620 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 679 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 686 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 693 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 694 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 695 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 762 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 764 | 1 | Phosphoserine Ref.10 Ref.15 | ||||||
| Modified residue | 765 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 769 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 771 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 777 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 784 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 801 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 805 | 1 | Phosphothreonine Ref.10 | ||||||
| Modified residue | 868 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 870 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 871 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 875 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 877 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 906 | 1 | Phosphoserine Ref.7 Ref.9 Ref.10 Ref.13 Ref.14 Ref.15 | ||||||
| Modified residue | 914 | 1 | Phosphothreonine Ref.9 | ||||||
| Modified residue | 932 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 934 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 935 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 936 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 939 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 941 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 967 | 1 | Phosphoserine Ref.6 Ref.13 | ||||||
| Modified residue | 983 | 1 | Phosphothreonine Ref.13 | ||||||
| Modified residue | 996 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 997 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 998 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 999 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 1001 | 1 | Phosphoserine Ref.7 Ref.15 | ||||||
| Modified residue | 1111 | 1 | Phosphoserine Ref.6 Ref.8 Ref.15 | ||||||
| Modified residue | 1149 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1150 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1153 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1154 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1190 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1191 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1228 | 1 | Phosphoserine Ref.6 Ref.8 Ref.12 Ref.15 | ||||||
| Modified residue | 1234 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 1257 | 1 | Phosphoserine Ref.7 Ref.10 Ref.15 | ||||||
| Modified residue | 1350 | 1 | Phosphoserine Ref.7 Ref.9 Ref.10 Ref.14 Ref.15 | ||||||
| Modified residue | 1358 | 1 | Phosphothreonine Ref.10 Ref.15 | ||||||
| Modified residue | 1361 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 1376 | 1 | Phosphoserine Ref.6 Ref.10 Ref.15 | ||||||
| Modified residue | 1378 | 1 | Phosphoserine Ref.6 Ref.7 Ref.8 Ref.10 Ref.12 Ref.14 Ref.15 | ||||||
| Modified residue | 1407 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1410 | 1 | Phosphoserine Ref.11 Ref.15 | ||||||
| Modified residue | 1471 | 1 | Phosphoserine Ref.6 Ref.7 | ||||||
Natural variations | |||||||||
| Alternative sequence | 214 – 290 | 77 | Missing in isoform 2. | VSP_022295 | |||||
| Alternative sequence | 953 | 1 | Q → QDSNSKPARSKTLAPAPPER NTEGSSESSEEELPLTQ in isoform 4. | VSP_022296 | |||||
| Alternative sequence | 954 – 958 | 5 | VIKPP → DQESS in isoform 5. | VSP_023133 | |||||
| Alternative sequence | 959 – 1488 | 530 | Missing in isoform 5. | VSP_023134 | |||||
| Alternative sequence | 1172 | 1 | L → LV in isoform 2 and isoform 3. | VSP_022297 | |||||
| Natural variant | 53 | 1 | W → R in TCS. Ref.16 | VAR_005630 | |||||
| Natural variant | 221 | 1 | A → P: dbSNP rs11541811. | VAR_057002 | |||||
| Natural variant | 516 | 1 | P → L Ref.16 | VAR_005631 | |||||
| Natural variant | 665 | 1 | P → A: dbSNP rs2071240. Ref.5 | VAR_029869 | |||||
| Natural variant | 887 | 1 | A → V: dbSNP rs7713638. Ref.16 Ref.5 | VAR_005632 | |||||
| Natural variant | 1030 | 1 | R → K in a colorectal cancer sample; somatic mutation. Ref.17 | VAR_035666 | |||||
| Natural variant | 1390 | 1 | A → V: dbSNP rs15251. Ref.16 | VAR_005633 | |||||
| Natural variant | 1432 | 1 | D → G Ref.16 | VAR_005634 | |||||
Experimental info | |||||||||
| Sequence conflict | 1389 | 1 | K → Q in AAB40722. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome." Dixon J., Edwards S.J., Gladwin A.J., Dixon M.J., Loftus S.K., Bonner C.A., Koprivnikar K., Wasmuth J.J. Nat. Genet. 12:130-136(1996) [PubMed: 8563749] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [2] | "Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene." Dixon J., Edwards S.J., Anderson I., Brass A., Scambler P.J., Dixon M.J. Genome Res. 7:223-234(1997) [PubMed: 9074926] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. |
| [3] | "TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout its coding region." Wise C.A., Chiang L.C., Paznekas W.A., Sharma M., Musy M.M., Ashley J.A., Lovett M., Jabs E.W. Proc. Natl. Acad. Sci. U.S.A. 94:3110-3115(1997) [PubMed: 9096354] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. |
| [4] | "Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons." So R.B., Gonzales B., Henning D., Dixon J., Dixon M.J., Valdez B.C. Gene 328:49-57(2004) [PubMed: 15019983] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORM 4). |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-1188 (ISOFORM 3), VARIANTS ALA-665 AND VAL-887. Tissue: Eye and Skin. |
| [6] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-967; SER-1111; SER-1228; SER-1376; SER-1378 AND SER-1471, MASS SPECTROMETRY. Tissue: Epithelium. |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; THR-84; SER-85; SER-87; SER-88; SER-164; SER-171; SER-233; SER-446; SER-475; SER-477; SER-478; SER-479; SER-482; SER-484; SER-608; SER-610; SER-611; SER-614; SER-615; SER-617; SER-620; SER-868; SER-870; SER-871; SER-875; SER-877 AND SER-906; SER-932; SER-934; SER-935; SER-936; SER-939; SER-941; SER-996; SER-997; SER-998; SER-999; SER-1001; SER-1257; SER-1350; SER-1378 AND SER-1471, MASS SPECTROMETRY. Tissue: Epithelium. |
| [8] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-249; SER-1111; SER-1228 AND SER-1378, MASS SPECTROMETRY. Tissue: Epithelium. |
| [9] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-304; THR-310; THR-316; SER-381; SER-446; SER-582; SER-583; SER-906; THR-914 AND SER-1350, MASS SPECTROMETRY. Tissue: Epithelium. |
| [10] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138; THR-144; SER-153; SER-160; SER-381; THR-394; SER-446; SER-583; SER-764; SER-784; SER-801; THR-805; SER-906; SER-1257; SER-1350; THR-1358; SER-1361; SER-1376 AND SER-1378, MASS SPECTROMETRY. |
| [11] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1410, MASS SPECTROMETRY. |
| [12] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-156; SER-381; SER-582; SER-583; SER-1228 AND SER-1378, MASS SPECTROMETRY. |
| [13] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906; SER-967 AND THR-983, MASS SPECTROMETRY. |
| [14] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906; SER-1350 AND SER-1378, MASS SPECTROMETRY. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; THR-84; SER-85; SER-87; SER-88; SER-153; SER-156; THR-249; THR-310; THR-316; SER-381; SER-503; THR-581; SER-583; SER-762; SER-764; SER-765; SER-769; SER-771; SER-777; SER-868; SER-870; SER-871; SER-875; SER-877; SER-906; SER-996; SER-997; SER-998; SER-999; SER-1001; SER-1111; SER-1190; SER-1191; SER-1228; THR-1234; SER-1257; SER-1350; THR-1358; SER-1376; SER-1378; SER-1407 AND SER-1410, MASS SPECTROMETRY. |
| [16] | "The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon." Edwards S.J., Gladwin A.J., Dixon M.J. Am. J. Hum. Genet. 60:515-524(1997) [PubMed: 9042910] [Abstract] Cited for: VARIANTS LEU-516; VAL-887; VAL-1390 AND GLY-1432, VARIANT TCS ARG-53. |
| [17] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] LYS-1030. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| U40847 mRNA. Translation: AAC50903.1. U76366 mRNA. Translation: AAC51181.1. U84664 U84663 Genomic DNA. Translation: AAC51185.1. U79659 U79658 Genomic DNA. Translation: AAB40722.1. AY460334 mRNA. Translation: AAR87774.1. BC011764 mRNA. Translation: AAH11764.1. BC014559 mRNA. Translation: AAH14559.1. BC027252 mRNA. Translation: AAH27252.1. BC033093 mRNA. Translation: AAH33093.1. | |
| IPI | IPI00298696. IPI00555853. IPI00815713. IPI00815731. IPI00815944. |
| RefSeq | NP_000347.2. NP_001008657.1. NP_001128715.1. NP_001128717.1. |
| UniGene | Hs.519672 Hs.605019 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q13428. 5 interactions. |
PTM databases | |
| PhosphoSite | Q13428. |
Proteomic databases | |
| PRIDE | Q13428. |
Genome annotation databases | |
| Ensembl | ENSG00000070814. Homo sapiens. [Contig view] |
| GeneID | 6949. |
| UCSC | uc003lrw.1. human. uc003lry.1. human. uc003lsa.1. human. |
Organism-specific databases | |
| GeneCards | GC05P149717. |
| H-InvDB | HIX0005313. |
| HGNC | HGNC:11654. TCOF1. |
| MIM | 154500. phenotype. 606847. gene. |
| Orphanet | 861. Treacher-Collins syndrome. |
| PharmGKB | PA36405. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | Q13428. |
Gene expression databases | |
| ArrayExpress | Q13428. |
| Bgee | Q13428. |
| CleanEx | HS_TCOF1. |
| GermOnline | ENSG00000070814. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR006594. LisH_dimerisation. IPR003993. TCS_treacle. IPR017859. TCS_treacle-like. [Graphical view] |
| Pfam | PF03546. Treacle. 3 hits. [Graphical view] |
| PRINTS | PR01503. TREACLE. |
| SMART | SM00667. LisH. 1 hit. [Graphical view] |
| PROSITE | PS50896. LISH. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 27207. |
| PMAP-CutDB | Q13428. |
| SOURCE | Search... |
Entry information
| Entry name | TCOF_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13428 Secondary accession number(s): Q6SC72 Q99860 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


